REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170 | +3.6% | 42,278 | +0.2% | 0.00% | +100.0% |
| Q2 2023 | $1,129 | +7.3% | 42,203 | -13.1% | 0.00% | 0.0% |
| Q1 2023 | $1,052 | -18.9% | 48,551 | -10.8% | 0.00% | -50.0% |
| Q4 2022 | $1,297 | -99.9% | 54,453 | +8.6% | 0.00% | +100.0% |
| Q3 2022 | $989,000 | +18.7% | 50,130 | +17.3% | 0.00% | 0.0% |
| Q2 2022 | $833,000 | -23.8% | 42,739 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,093,000 | +1.5% | 42,834 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $1,077,000 | -8.8% | 42,788 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,181,000 | -27.5% | 42,933 | -16.4% | 0.00% | -50.0% |
| Q2 2021 | $1,630,000 | +1.8% | 51,349 | +47.1% | 0.00% | 0.0% |
| Q1 2021 | $1,601,000 | +15.8% | 34,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,382,000 | +13.7% | 34,900 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $1,215,000 | +200.7% | 34,900 | +172.7% | 0.00% | 0.0% |
| Q2 2020 | $404,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |